Cancer

Parexel Appoints Gwyn Bebb, BM, BCh., Ph.D., to Lead Oncology Clinical Development

Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need Parexel Gwyn Bebb, BM, BCh., Ph.D., Senior Vice…

1 year ago

Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software

Dedicated team of global regulatory experts delivers submissions in increasingly shorter timelinesPRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Certara,…

1 year ago

Panbela to Present at the LD Micro Investor Conference

MINNEAPOLIS, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the…

1 year ago

IN8bio Strengthens Intellectual Property Portfolio with Newly Granted Global Patents

Newly granted patents expand the use of the DeltEx Drug Resistant Immunotherapy (DRI) platform to encompass Chimeric Antigen Receptor T-cell…

1 year ago

Clarivate Unveils Citation Laureates 2023 – Annual List of Researchers of Nobel Class

71 Citation Laureates named by the Institute for Scientific Information have gone on to receive a Nobel Prize LONDON, Sept.…

1 year ago

Wildfire Smoke Provides Stark Reminder of Challenges Faced by Canadian Pulmonary Fibrosis Patients

Many of Canada's 30,000 PF patients who struggle to breathe, can't get the oxygen they need.Markham, Ontario--(Newsfile Corp. - September…

1 year ago

Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers – Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment

SEATTLE, WA / ACCESSWIRE / September 18, 2023 / One in eight women will be diagnosed with breast cancer during…

1 year ago

TRIANA Biomedicines to Present at UBS Biotechnology Private Company Virtual Symposium

LEXINGTON, MA / ACCESSWIRE / September 18, 2023 / TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmaceutical company focused on advancing…

1 year ago

Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company

AI-powered target discovery for a bacterial pathogen with a high medical need where no vaccine is currently available Evaxion’s proprietary AI-platforms…

1 year ago

Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer

Research will use Myriad’s high-definition MRD testing platform based on whole-genome sequencingSALT LAKE CITY, Sept. 18, 2023 (GLOBE NEWSWIRE) --…

1 year ago